Statin therapy in COVID-19 infection

Eur Heart J Cardiovasc Pharmacother. 2020 Jul 1;6(4):258-259. doi: 10.1093/ehjcvp/pvaa042.

Authors

Vincenzo Castiglione¹, Martina Chiriacò^{1

2}, Michele Emdin^{1

3}, Stefano Taddei², Giuseppe Vergaro^{1

3}

Affiliations

¹ Institute of Life Science, Scuola Superiore Sant'Anna, Pisa, Italy.
² Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy.
³ Fondazione Toscana Gabriele Monasterio, Pisa, Italy.

No abstract available

Publication types

Letter
Comment

MeSH terms

Betacoronavirus
COVID-19
Cardiovascular System*
Coronavirus Infections*
Coronavirus*
Humans
Hydroxymethylglutaryl-CoA Reductase Inhibitors*
Pandemics*
Pneumonia, Viral*
SARS-CoV-2

Substances

Hydroxymethylglutaryl-CoA Reductase Inhibitors